Bosentan Monohydrate is a medication primarily prescribed to treat pulmonary arterial hypertension (PAH). PAH is a serious condition characterized by high blood pressure in the arteries of the lungs, which can lead to difficulty breathing and reduced exercise capacity.
Pulmonary Arterial Hypertension:
Adult: Initially 62.5 Mg Twice Daily For 4 Weeks, Then Increased To 125 Mg Twice Daily (max. Per Dose 250 Mg); Maximum 500 Mg Per Day
Children: Not Recommended.
Systemic Sclerosis With Ongoing Digital Ulcer Disease To Reduce Number Of New Digital Ulcers:
Adult: Initially 62.5 Mg Twice Daily For 4 Weeks, Then Increased To 125 Mg Twice Daily
Children: Not Recommended.
Content
Tab: Bosentan 62.5mg (as Monohydrate).
Pregnancy
Contraindicated In Pregnancy.
Stability
Endothelin Receptor Antagonist
Contra Indications
Hepatic Impairment, Hepatic Aminotransferase Levels >3x Upper Limit, Acute Porphyrias, Not To Be Initiated If Systemic Systolic Blood Pressure Is Below 85mmhg
Precautions
Hepatic Impairment, Hepatic Aminotransferase Levels >3x Upper Limit, Acute Porphyrias, Not To Be Initiated If Systemic Systolic Blood Pressure Is Below 85mmhg